Skip to main content

Fecal Microbiota Transplant No Aid for Parkinson Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 2, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Aug. 2, 2024 -- Fecal microbiota transplantation (FMT) is safe but does not offer clinically meaningful improvements for Parkinson disease (PD), according to a study published online July 29 in JAMA Neurology.

Filip Scheperjans, M.D., Ph.D., from Helsinki University Hospital, and colleagues randomly assigned (2:1) 47 patients with PD (aged 35 to 75 years) in Hoehn & Yahr stage 1 to 3 and dysbiosis of fecal microbiota to receive FMT or placebo via colonoscopy.

The researchers found that the primary outcome of change of Movement Disorder Society Unified Parkinson’s Disease Rating Scale parts I-III (part III off medication) at six months did not differ between the groups. The FMT group had more gastrointestinal adverse events more frequently (16 versus 1). In the placebo group, there was a stronger increase in dopaminergic medication and improvement of certain motor and nonmotor outcomes. While microbiota changes were more pronounced after FMT, they differed by donor. Yet, in the placebo group, dysbiosis status was reversed more frequently.

"Further studies -- for example, through modified FMT approaches or bowel cleansing -- are warranted regarding the specific impact of donor microbiota composition and dysbiosis conversion on motor and nonmotor outcomes as well as medication needs in PD," the authors write.

Several authors disclosed ties to the pharmaceutical and biotechnology industries.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted August 2024

Read this next

Common Medications Tied to Older Age at Onset of Parkinson Disease

FRIDAY, April 25, 2025 -- Multiple common medications are associated with a considerable delay of Parkinson disease (PD) symptom onset, according to a study published online March...

Gastrointestinal Disease Tied to High Physical, Financial Burden

FRIDAY, April 18, 2025 -- Gastrointestinal (GI) diseases are responsible for a considerable and growing burden of health care use and costs within the United States, according to...

AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease

TUESDAY, April 8, 2025 -- For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.